Cornea Service, Wills Eye Institute, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Cornea. 2010 Mar;29(3):254-9. doi: 10.1097/ICO.0b013e3181b31b6f.
The purposes of this study were to report the indications, graft survival, risk factors for graft failure, and visual outcomes for third or greater penetrating keratoplasties (PKP).
Six years of Wills Eye Institute Cornea Service charts (2000-2005) were retrospectively reviewed to identify all patients who had undergone three or more PKPs. Graft survival rates by initial diagnosis and risk factors for graft failure were analyzed.
Forty-five patients who had three or more PKPs were identified. The total number of grafts identified in these 45 patients was 152, including 45 third PKPs, 11 fourth, three fifth, two sixth, and one seventh. The most common indication for the initial PKP was pseudophakic bullous keratopathy in 18 of 45 patients (41%) followed by Fuchs dystrophy (seven of 45 patients [16%]) and stromal dystrophies (five of 45 patients [11%]). Approximately half of third grafts (24 of 45 [53%]) and one fourth of fourth grafts (three of 11 [27%]) survived at the last follow-up visit with a median follow up of 4.3 years for the third grafts and 8.4 years for the fourth grafts. One-, 2-, and 5-year graft survival rates were 89%, 78%, and 53% for the third grafts and 73%, 73%, and 64% for the fourth grafts, respectively. The median survival time for the third graft was 12.8 years in Fuchs dystrophy, 5.2 years in herpetic keratitis, 4.0 years in keratoconus, 3.0 years in pseudophakic bullous keratopathy, 2.3 years in iridocorneal endothelial syndrome, and 2.0 years in stromal dystrophies. There is no statistically significant difference between groups (P = 0.46). Risk factor analysis on the third grafts showed that previous glaucoma procedures and corneal neovascularization are statistically significant risk factors for graft failure (P = 0.04 and 0.02, respectively).
Over 50% of third and fourth grafts were clear at 5 years postoperatively. Outcomes of third grafts were better in patients with Fuchs dystrophy, keratoconus, and herpetic keratitis. Absence of previous glaucoma surgery and/or corneal neovascularization is associated with better outcomes of multiple PKPs.
本研究旨在报告第 3 次或以上穿透性角膜移植术(PKP)的适应证、移植物存活率、移植物失败的危险因素和视力结果。
回顾性分析威尔斯眼研究所角膜服务图表(2000-2005 年)6 年的数据,以确定所有接受 3 次或以上 PKP 的患者。分析初始诊断的移植物存活率和移植物失败的危险因素。
确定了 45 例接受 3 次或以上 PKP 的患者。在这 45 例患者中,共发现 152 个移植物,包括 45 个第 3 次 PKP、11 个第 4 次、3 个第 5 次、2 个第 6 次和 1 个第 7 次。第 1 次 PKP 的最常见适应证是 18 例患者(41%)的白内障性大泡性角膜病变,其次是 Fuchs 营养不良(7 例患者 [16%])和基质营养不良(5 例患者 [11%])。第 3 次移植物中有近一半(24 例患者中的 24 例 [53%])和第 4 次移植物中有四分之一(11 例患者中的 3 例 [27%])在最后一次随访时存活,第 3 次移植物的中位随访时间为 4.3 年,第 4 次移植物的中位随访时间为 8.4 年。第 3 次移植物的 1、2 和 5 年移植物存活率分别为 89%、78%和 53%,第 4 次移植物分别为 73%、73%和 64%。第 3 次移植物在 Fuchs 营养不良患者中的中位存活时间为 12.8 年,在疱疹性角膜炎患者中为 5.2 年,在圆锥角膜患者中为 4.0 年,在白内障性大泡性角膜病变患者中为 3.0 年,在虹膜角膜内皮综合征患者中为 2.3 年,在基质营养不良患者中为 2.0 年。组间无统计学显著差异(P = 0.46)。第 3 次移植物的风险因素分析显示,既往青光眼手术和角膜新生血管化是移植物失败的统计学显著危险因素(P = 0.04 和 0.02)。
超过 50%的第 3 次和第 4 次移植物在术后 5 年时是透明的。Fuchs 营养不良、圆锥角膜和疱疹性角膜炎患者的第 3 次移植物结果更好。无既往青光眼手术和/或角膜新生血管化与多次 PKP 的更好结果相关。